Total Payments
$2,343
2024 Payments
$1,293
Companies
24
Transactions
139
Medicare Patients
417
Medicare Billing
$52,160
Payment Breakdown by Category
Food & Beverage$2,343 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,343 | 139 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $552.07 | 38 | $0 (2024) |
| ABBVIE INC. | $468.95 | 25 | $0 (2024) |
| QOL Medical, LLC | $193.89 | 9 | $0 (2024) |
| Lilly USA, LLC | $160.28 | 10 | $0 (2024) |
| Celgene Corporation | $120.79 | 8 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $118.45 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $101.93 | 6 | $0 (2024) |
| PFIZER INC. | $70.26 | 4 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $65.40 | 4 | $0 (2024) |
| Ardelyx, Inc. | $57.78 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,293 | 81 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($402.04) |
| 2023 | $807.55 | 48 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($135.61) |
| 2022 | $242.09 | 10 | ABBVIE INC. ($131.33) |
All Payment Transactions
139 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Gastroenterology | ||||||
| 12/12/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/10/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: LIVER DISEASE | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $17.98 | General |
| 11/06/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Gastroenterology | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Gastroenterology | ||||||
| 10/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/08/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Gastroenterology | ||||||
| 10/01/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.78 | General |
| 09/24/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Gastroenterology | ||||||
| 09/12/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Gastroenterology | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Gastroenterology | ||||||
| 09/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $5.79 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 310 | 367 | $181,813 | $39,426 |
| 2022 | 3 | 107 | 162 | $51,664 | $12,734 |
Total Patients
417
Total Services
529
Medicare Billing
$52,160
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 38 | 40 | $38,240 | $8,813 | 23.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 48 | 75 | $27,225 | $8,321 | 30.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $32,509 | $7,254 | 22.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 37 | 62 | $14,880 | $4,194 | 28.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 32 | 32 | $14,368 | $3,448 | 24.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 40 | 40 | $30,240 | $3,192 | 10.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 26 | 28 | $14,588 | $2,080 | 14.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $6,552 | $1,182 | 18.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 13 | $3,211 | $940.96 | 29.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 55 | 106 | $25,440 | $6,434 | 25.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 38 | 41 | $18,409 | $4,721 | 25.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 14 | 15 | $7,815 | $1,579 | 20.2% |
About Ari Young
Ari Young is a Gastroenterology healthcare provider based in Summit, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2016. The National Provider Identifier (NPI) number assigned to this provider is 1609220763.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ari Young has received a total of $2,343 in payments from pharmaceutical and medical device companies, with $1,293 received in 2024. These payments were reported across 139 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,343).
As a Medicare-enrolled provider, Young has provided services to 417 Medicare beneficiaries, totaling 529 services with total Medicare billing of $52,160. Data is available for 2 years (2022–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Summit, NJ
- Active Since 04/14/2016
- Last Updated 09/14/2022
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1609220763
Products in Payments
- XIFAXAN (Drug) $411.82
- RINVOQ (Biological) $197.13
- TRULANCE (Drug) $123.58
- ZEPOSIA (Drug) $120.79
- SUCRAID (Drug) $112.22
- ENTYVIO (Biological) $103.39
- SKYRIZI (Biological) $83.67
- Sucraid (Drug) $81.67
- XELJANZ (Drug) $70.26
- OMVOH (Drug) $66.49
- REBYOTA (Biological) $65.40
- IBSRELA (Drug) $57.78
- DIFICID (Drug) $54.97
- TREMFYA (Drug) $54.17
- REMICADE (Biological) $47.76
- ZENPEP (Drug) $46.15
- CeQur Simplicity (Device) $43.80
- DUPIXENT (Biological) $43.78
- Tymlos (Drug) $40.60
- TERIPARATIDE (Drug) $35.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.